MM

Michael McGlinn

Executive Director, Market Access, Strategic Accounts & Pricing at Intercept Pharmaceuticals

Michael McGlinn has extensive work experience in the pharmaceutical industry, with a focus on market access and payer contracting. Michael has held various senior roles in companies such as Intercept Pharmaceuticals and Purdue Pharma.

At Intercept Pharmaceuticals, Michael served as the Executive Director of Market Access, Strategic Accounts, and Pricing, where they were responsible for developing contracting infrastructure and strategies for the launch of a new product in the NASH market. Michael also led a cross-functional team to ensure readiness for the launch.

Prior to their role at Intercept, Michael worked at Purdue Pharma, where they held several leadership positions. As the Executive Director of Managed Markets, they successfully executed contracting strategies and achieved profitable access for the company's product, Symproic. Michael also transformed the payer contracting process and implemented new contract profitability tools as the Director of Managed Markets Contracting.

Throughout their career, Michael has demonstrated strong relationship-building skills and has been recognized for their achievements. Michael has received awards for their performance as a Regional Account Executive and Professional Sales Representative at Purdue Pharma.

Overall, Michael McGlinn has a proven track record in market access, payer contracting, and successful product launches in the pharmaceutical industry.

Michael McGlinn has a Bachelor of Arts degree in Political Science with Honors from Villanova University. Michael also completed the Purdue Accelerator Program at the Yale School of Management in 2017. Additionally, they hold an MBA from NYU Stern School of Business. Lastly, they attended Iona Preparatory.

Links

Peers

View in org chart

Timeline

  • Executive Director, Market Access, Strategic Accounts & Pricing

    January, 2022 - present

  • Interim Head Of US Market Access

    August, 2019

  • Sr Director US Market Access Execution Operation

    April, 2019